Roy G P J de Jong
Overview
Explore the profile of Roy G P J de Jong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong R, Peeters P, Burden A, De Bruin M, Haak H, Masclee A, et al.
Cancer Epidemiol
. 2018 Apr;
54:104-111.
PMID: 29705628
Background: Patients with type 2 diabetes mellitus (T2DM) have been shown to have higher incidences of liver, pancreatic, and colorectal cancer compared to non-diabetic individuals. Current evidence is conflicting for...
2.
Knapen L, de Jong R, Driessen J, Keulemans Y, van Erp N, De Bruin M, et al.
Diabetes Obes Metab
. 2016 Nov;
19(3):401-411.
PMID: 27883260
Aim: To determine the association between the use of incretin agents (dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists) for the treatment of type 2 diabetes mellitus (T2DM) and the...
3.
de Jong R, Gallagher A, Herrett E, Masclee A, Janssen-Heijnen M, de Vries F
Pharmacoepidemiol Drug Saf
. 2016 Jul;
25(12):1460-1464.
PMID: 27465256
Purpose: The UK Clinical Practice Research Datalink (CPRD) is increasingly being used by Dutch researchers in epidemiology and pharmacoepidemiology. It is however unclear if the UK CPRD is representative of...
4.
de Jong R, Nielen J, Masclee A, Janssen-Heijnen M, de Vries F
Eur J Cancer
. 2016 May;
61:157-8.
PMID: 27131610
No abstract available.